Skip to main content
Ashley Rosko, MD, Oncology, Columbus, OH, The OSUCCC - James

AshleyElizabethRoskoMD

Oncology • Columbus, OH

Hematologic Oncology

Professor - Clinical, Dept of Internal Medicine, Division of Hematology, Ohio State University College of Medicine

Join to view full profile

Dr. Rosko is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rosko's full profile

Already have an account?

  • Office

    320 W. 10th Ave
    A345 Starling Loving Hall
    Columbus, OH 43210
    Phone+1 614-293-7807
    Fax+1 614-293-6420
  • Is this information wrong?

Education & Training

  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2006 - 2010
  • Wright State University Boonshoft School of Medicine
    Wright State University Boonshoft School of MedicineClass of 2006

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2009 - 2026
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Director Blood Cancer and Aging Clinical Program, 2016
  • Cancer and Aging Care Delivery The Service Board Ohio State University, 2016
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma.  
    Rosko A, Hofmeister C, Benson D, Efebera Y, Huang Y, Gillahan J, Byrd JC, Burd CE, BMT, 6/2015

Abstracts/Posters

  • Phase I Dose-Escalation Study of Venetoclax Plus BEAM Followed By Autologous Stem Cell Transplant (ASCT) for Chemoresistant or High-Risk Relapsed/Refractory Non-Hodgki...
    Ashley E. Rosko, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Effect of Early Post Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
    Ashley E. Rosko, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Improvement in Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience
    Ashley E. Rosko, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Role of Geriatric Assessment in Newly Diagnosed Multiple Myeloma 
    ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
  • Restoring Functional Deficits in Older Adults with Hematologic Malignancy 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Friday Scientific Workshop on Hematology and Aging: From Bleeding Disorders to Malignant Hematology 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Press Mentions

  • Frontline Therapy for Multiple Myeloma
    Frontline Therapy for Multiple MyelomaMay 3rd, 2022
  • Transplant in Multiple Myeloma Deemed Safe in Older Patients — but Is It Necessary?
    Transplant in Multiple Myeloma Deemed Safe in Older Patients — but Is It Necessary?January 27th, 2020
  • Strategies Explored to Enhance Treatment of Elderly Myeloma Patients
    Strategies Explored to Enhance Treatment of Elderly Myeloma PatientsOctober 11th, 2017
  • Join now to see all

Grant Support

  • K23NIH NCI2016–2021

Hospital Affiliations

Dr. Ashley Rosko, Dr. Ashley Rosko, MD, Dr. A Rosko, Dr. Ashley Elizabeth Rosko